Insulin with a stable basal release profile

Date

2011-5-12

Author

Pohl, Roderike
Kashyap, Nandini
Hauser, Robert
Özhan, Koray

Metadata

Show full item record

Item Usage Stats

234
views

0
downloads

A basal insulin formulation composed of insulin, preferably insulin glargine, injectable zinc and injectable iron compounds as precipitating and/or stabilizing agents has been developed for subcutaneous, intradermal or intramuscular administration. The formulation is designed to form a precipitate of insulin following injection, creating a slow releasing "basal insulin" over a period of 12 to 24 hours.

URI

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2011143421&_cid=P12-KJTN7W-94705-1
https://hdl.handle.net/11511/70176

Collections

Graduate School of Marine Sciences, Patent / Utility Model

Suggestions

OpenMETU
Core

Insulin with a basal release profile Pohl, Roderike; Kashyap, Nandini; Hauser, Robert; Özhan, Koray; Steıner, Solomon S. (Dünya Fikri Mülkiyet Teşkilatı, 2009-9-2) A clear basal insulin formulation composed of insulin (preferably human recombinant insulin), buffering agents, precipitating agents, and/or stabilizing agents for subcutaneous, intradermal or intramuscular administration. The formulation is designed to form a precipitate of insulin following injection, creating a slow releasing "basal insulin" over a period of 12 to 24 hours, which can be varied by compositional changes to tailor the release profile to the needs of the individual diabetic patient.
Diabetes induces compositional, structural and functional alterations on rat skeletal soleus muscle revealed by FTIR spectroscopy: a comparative study with EDL muscle Bozkurt, Ozlem; Severcan, Mete; Severcan, Feride (2010-01-01) Diabetes Mellitus (DM) is a metabolic disorder, characterized by abnormally high blood glucose levels due to decreased secretion or effectiveness in function of insulin. Having a role in carbohydrate and lipid metabolism, skeletal muscle is affected by the absence of insulin in diabetic conditions. This current study reports the application of Fourier transform infrared (FTIR) spectroscopy in the determination of macromolecular alterations in streptozotocin (STZ)-induced diabetic rat skeletal Soleus (SOL) m...
Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge masking POHL, Roderike; HAUSER, Robert; Lİ, Ming; De Souza, Errol; FELDSTEİN, Robert; SEİBERT, Richard; Özhan, Koray; Kashyap, Nandini; STEİNER, Solomon (2012-01-01) In order to enhance the absorption of insulin following subcutaneous injection, excipients were selected to hasten the dissociation rate of insulin hexamers and reduce their tendency to reassociate postinjection. A novel formulation of recombinant human insulin containing citrate and disodium ethylenediaminetetraacetic acid (EDTA) has been tested in clinic and has a very rapid onset of action in patients with diabetes. In order to understand the basis for the rapid insulin absorption, in vitro experiments u...
Metabolic network analysis for human therapeutic protein productions: Effects of the P/O ratio Çalık, Pınar (2000-10-08) The metabolic fluxes through the central carbon pathways in the bioprocesses for human leukocyte interferon (IFN-alpha(1)) and erythropoietin (EPO) overproductions by recombinant Bacillus sp, carrying the related human genes were determined separately, on two alternative carbon sources, i.e. glucose and citrate, which have different reduction degrees. In addition, the influence of the P/O ratio on the cell growth, IFN-alpha(1) and EPO productions were investigated. Thus, the potential influence of increased...
Investigation of docetaxel and doxorubicin resistance in mcf-7 breast carcinoma cell line Darcansoy İşeri, Özlem; Gündüz, Ufuk; Department of Biotechnology (2009) Multidrug resistance phenotype of tumor cells describes resistance to wide range of structurally unrelated anticancer agents and is a serious limitation to effective chemotherapy. It is a multifactor yet not fully elucidated phenomenon by the involvement of diverse cellular pathways. Aim of this study was to investigate the resistance mechanisms developed against docetaxel and doxorubicin that are widely used in the treatment of breast cancer in model cell line MCF-7. Resistant sublines were developed by ap...

Citation Formats

R. Pohl, N. Kashyap, R. Hauser, and K. Özhan, “Insulin with a stable basal release profile,” 00, 2011.